HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shan Jiang Selected Research

Insulin Antibodies

10/2021Comparable efficacy and safety between LY2963016 insulin glargine and insulin glargine (Lantus®) in Chinese patients with type 1 diabetes: A phase III, randomized, controlled trial.
1/2021Efficacy and safety of LY2963016 insulin glargine versus insulin glargine (Lantus) in Chinese adults with type 2 diabetes: A phase III, randomized, open-label, controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shan Jiang Research Topics

Disease

89Neoplasms (Cancer)
07/2022 - 01/2007
30Inflammation (Inflammations)
10/2022 - 06/2011
15Prostatic Neoplasms (Prostate Cancer)
07/2022 - 01/2008
14Obesity
10/2021 - 11/2008
13Neoplasm Metastasis (Metastasis)
01/2022 - 02/2011
13Hypertension (High Blood Pressure)
01/2022 - 03/2004
12Infections
07/2022 - 01/2007
12Fibrosis (Cirrhosis)
04/2022 - 09/2008
12Breast Neoplasms (Breast Cancer)
01/2021 - 03/2007
11Carcinogenesis
12/2021 - 08/2003
11Alzheimer Disease (Alzheimer's Disease)
12/2021 - 01/2015
10Uterine Cervical Neoplasms (Cancer of the Cervix)
08/2022 - 01/2015
10Hypoxia (Hypoxemia)
12/2021 - 10/2012
9Necrosis
11/2021 - 09/2005
8Cardiovascular Diseases (Cardiovascular Disease)
11/2022 - 06/2009
8Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 08/2017
8Wounds and Injuries (Trauma)
12/2021 - 12/2011
7Type 2 Diabetes Mellitus (MODY)
11/2021 - 02/2015
7Melanoma (Melanoma, Malignant)
10/2020 - 01/2008
7Non-alcoholic Fatty Liver Disease
01/2020 - 04/2011
7Liver Cirrhosis (Hepatic Cirrhosis)
11/2019 - 07/2006
7Insulin Resistance
08/2015 - 01/2011
7Tuberculosis (Tuberculoses)
05/2014 - 04/2004
6Pancreatic Neoplasms (Pancreatic Cancer)
03/2022 - 01/2018
6Cognitive Dysfunction
02/2022 - 01/2015
6Hepatocellular Carcinoma (Hepatoma)
01/2022 - 08/2003
6Pathologic Processes
01/2022 - 06/2013
6Lung Neoplasms (Lung Cancer)
12/2021 - 07/2011
5Chronic Obstructive Pulmonary Disease (COPD)
08/2022 - 01/2019
5Stroke (Strokes)
06/2022 - 06/2009
5Liver Neoplasms (Liver Cancer)
05/2022 - 08/2003
5Pneumonia (Pneumonitis)
04/2022 - 04/2019
5Fatigue
03/2022 - 01/2015
5Dental Caries (Decay, Dental)
03/2022 - 02/2016
5COVID-19
01/2022 - 01/2021
5Gestational Diabetes (Gestational Diabetes Mellitus)
01/2022 - 10/2017
5Ischemia
01/2022 - 11/2008
5Atherosclerosis
01/2022 - 01/2016
5Chronic Renal Insufficiency
01/2022 - 11/2019
5Proteinuria
01/2021 - 12/2011
5Neuroblastoma
01/2021 - 10/2012
5Hyperglycemia
01/2019 - 11/2012
4Pulmonary Fibrosis (Fibrosing Alveolitis)
08/2022 - 02/2016
4Vitiligo
01/2022 - 11/2019
4Thyroid Neoplasms (Thyroid Cancer)
01/2022 - 01/2018
4Acute Kidney Injury (Acute Renal Failure)
01/2022 - 01/2010
4Type 1 Diabetes Mellitus (Autoimmune Diabetes)
10/2021 - 10/2012
4Mitochondrial Diseases (Mitochondrial Disease)
01/2021 - 06/2013
4Carcinoma (Carcinomatosis)
01/2020 - 01/2011
4Body Weight (Weight, Body)
01/2019 - 06/2011

Drug/Important Bio-Agent (IBA)

32Proteins (Proteins, Gene)FDA Link
07/2022 - 04/2004
20Pharmaceutical PreparationsIBA
08/2022 - 09/2005
20Glucose (Dextrose)FDA LinkGeneric
01/2022 - 05/2005
19Biomarkers (Surrogate Marker)IBA
07/2022 - 08/2011
13MicroRNAs (MicroRNA)IBA
07/2022 - 03/2013
13Messenger RNA (mRNA)IBA
01/2022 - 03/2011
13RNA (Ribonucleic Acid)IBA
01/2022 - 05/2008
11Biological ProductsIBA
01/2022 - 06/2007
10Long Noncoding RNAIBA
05/2022 - 01/2015
10Small Interfering RNA (siRNA)IBA
12/2021 - 07/2006
10EnzymesIBA
04/2019 - 08/2013
9LipidsIBA
01/2022 - 06/2009
9Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 05/2010
9CytokinesIBA
01/2022 - 01/2008
8Insulin (Novolin)FDA Link
01/2021 - 10/2012
8Blood Glucose (Blood Sugar)IBA
01/2021 - 10/2012
7LipopolysaccharidesIBA
12/2022 - 09/2005
7Angiotensin IIIBA
10/2021 - 03/2011
6Therapeutic UsesIBA
08/2022 - 05/2005
6AntioxidantsIBA
11/2021 - 09/2014
6CreatinineIBA
01/2020 - 12/2011
6Apolipoproteins E (ApoE)IBA
01/2019 - 01/2015
5Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 03/2011
5Transcription Factors (Transcription Factor)IBA
01/2022 - 01/2012
5Testosterone (Sustanon)FDA Link
12/2021 - 10/2018
5Telomerase (Telomerase Reverse Transcriptase)IBA
12/2021 - 08/2003
5Oxygen (Dioxygen)IBA
06/2021 - 05/2005
5AntibodiesIBA
01/2021 - 12/2012
5C-Reactive ProteinIBA
05/2020 - 06/2009
5Farnesyltranstransferase (Farnesyltransferase)IBA
01/2020 - 07/2013
5Circular RNAIBA
01/2020 - 07/2017
4CholesterolIBA
01/2022 - 01/2019
4ChromatinIBA
01/2022 - 06/2006
4Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2021 - 06/2011
4IronIBA
09/2020 - 09/2009
4CopperIBA
09/2020 - 05/2018
4VaccinesIBA
04/2020 - 01/2007
4Interleukin-6 (Interleukin 6)IBA
01/2020 - 01/2015

Therapy/Procedure

45Therapeutics
05/2022 - 01/2010
11Brachytherapy
08/2022 - 08/2010
8Immunotherapy
10/2021 - 01/2007
7Radiotherapy
01/2022 - 12/2012
7Drug Therapy (Chemotherapy)
01/2022 - 04/2012
5Castration
03/2022 - 01/2017
5Phototherapy (Light Therapy)
01/2022 - 01/2015
5Photochemotherapy (Photodynamic Therapy)
01/2021 - 01/2011
4Injections
01/2022 - 09/2015
4Catheters
01/2022 - 05/2020
4Aftercare (After-Treatment)
07/2021 - 07/2011
4Peritoneal Dialysis
11/2020 - 01/2015